Dyadic International Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:30 pm UTC| Business
JUPITER, Fla., Nov. 09, 2017 -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the...
Galena Biopharma Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:30 pm UTC| Business
SAN RAMON, Calif., Nov. 09, 2017 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported its financial...
McDermott Awarded Major EPCI Contract in Middle East
Nov 09, 2017 21:30 pm UTC| Business
Award testament to McDermott’s operational expertise in Middle EastMcDermott to provide full suite of EPCI services for significant scope of workAward to be reflected in McDermott’s Q4 2017 backlog DUBAI,...
Aptevo Therapeutics Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:30 pm UTC| Business
Strengthened Cash Position to Support Ongoing RD and Commercial Activities; Reported $107 Million in Cash at the End of the Third Quarter Expanded Novel Bispecific Antibody Portfolio Through Collaboration with Alligator...
Esperion to Participate in Fireside Chat at the Stifel 2017 Healthcare Conference
Nov 09, 2017 21:30 pm UTC| Business
Fireside Chat Webcast on Tuesday, November 14, 2017 at 8:45 a.m. Eastern Time ANN ARBOR, Mich., Nov. 09, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and...
PLx Pharma Inc. Reports Third Quarter 2017 Results
Nov 09, 2017 21:30 pm UTC| Business
HOUSTON, Nov. 09, 2017 -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81...
Forward Pharma to Participate in the Nordic-American Life Science Conference
Nov 09, 2017 21:30 pm UTC| Business
COPENHAGEN, Denmark, Nov. 09, 2017 -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in the Nordic-American Life...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update